Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16712 | 28229316 | Obes Surg | Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16713 | 28225987 | Arch Endocrinol Metab | Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist? | 2017 | Details |
| A16714 | 28225569 | J Magn Reson Imaging | Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time. | 2017 | Details |
| A16715 | 28225568 | J Magn Reson Imaging | Liver histology and diffusion-weighted MRI in children with nonalcoholic fatty liver disease: A MAGNET study. | 2017 | Details |
| A16716 | 28225357 | Phys Med Biol | Robust sound speed estimation for ultrasound-based hepatic steatosis assessment. | 2017 | Details |
| A16717 | 28225186 | Aliment Pharmacol Ther | Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A16718 | 28224373 | J Gen Intern Med | Drug-Induced Liver Injury in the Setting of Glycogenic Hepatopathy. | 2017 | Details |
| A16719 | 28223722 | World J Gastroenterol | To screen or not to screen? Celiac antibodies in liver diseases. | 2017 | Details |
| A16720 | 28223710 | Sci Rep | High-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16722 | 28223446 | Diabetes Care | Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action. | 2017 | Details |
| A16723 | 28223420 | Sci Signal | New connections: New targets for fighting hepatic steatosis. | 2017 | Details |
| A16724 | 28222828 | Nutr Res Rev | Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. | 2017 | Details |
| A16725 | 28221405 | Lakartidningen | [New guidelines for NAFLD – a Swedish perspective]. | 2017 | Details |
| A16726 | 28220621 | J Diabetes | Low prevalence of non-alcoholic fatty liver disease in patients with type 1 diabetes is associated with decreased subclinical cardiovascular disease. | 2017 | Details |
| A16727 | 28220495 | J Pharm Pharmacol | Influence of hyperglycemia on liver inflammatory conditions in the early phase of non-alcoholic fatty liver disease in mice. | 2017 | Details |
| A16728 | 28220039 | Int J Obes (Lond) | Hormone signaling and fatty liver in females: analysis of estrogen receptor α mutant mice. | 2017 | Details |
| A16729 | 28219837 | J Nutr Biochem | Chronic maternal calcium and 25-hydroxyvitamin D deficiency in Wistar rats programs abnormal hepatic gene expression leading to hepatic steatosis in female offspring. | 2017 | Details |
| A16730 | 28219123 | Hepatol Res | Identification of core gene networks and hub genes associated with progression of non-alcoholic fatty liver disease by RNA sequencing. | 2017 | Details |
| A16731 | 28218919 | Nat Med | Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates. | 2017 | Details |
| A16732 | 28218651 | Int J Mol Sci | Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas. | 2017 | Details |
| A16733 | 28218263 | Nat Rev Nephrol | Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. | 2017 | Details |
| A16734 | 28217260 | World J Hepatol | Robotic liver surgery is the optimal approach as bridge to transplantation. | 2017 | Details |
| A16735 | 28217250 | World J Hepatol | Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis. | 2017 | Details |
| A16736 | 28216979 | World J Gastroenterol | Association between endotoxemia and histological features of nonalcoholic fatty liver disease. | 2017 | Details |
| A16737 | 28216552 | Mar Drugs | Protective Effects and Mechanism of Meretrix meretrix Oligopeptides against Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16738 | 28215516 | Dig Liver Dis | AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. | 2017 | Details |
| A16739 | 28214827 | Cell Physiol Biochem | Potential Regulators Driving the Transition in Nonalcoholic Fatty Liver Disease: a Stage-Based View. | 2017 | Details |
| A16740 | 28214524 | Gastroenterology | Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16741 | 28214020 | J Hepatol | Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents. | 2017 | Details |
| A16742 | 28213828 | Eur J Pediatr | Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis. | 2017 | Details |
| A16743 | 28213091 | Toxicol Appl Pharmacol | Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity. | 2017 | Details |
| A16744 | 28212710 | Adv Clin Chem | CTRP1 in Liver Disease. | 2016 | Details |
| A16745 | 28212548 | Oncotarget | Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model. | 2017 | Details |
| A16746 | 28212301 | Mar Drugs | The Phytocomplex from Fucus vesiculosus and Ascophyllum nodosum Controls Postprandial Plasma Glucose Levels: An In Vitro and In Vivo Study in a Mouse Model of NASH. | 2017 | Details |
| A16747 | 28212052 | Radiology | Proton Density Fat Fraction Measurements at 1.5- and 3-T Hepatic MR Imaging: Same-Day Agreement among Readers and across Two Imager Manufacturers. | 2017 | Details |
| A16749 | 28211165 | Liver Int | A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD. | 2017 | Details |
| A16750 | 28211103 | J Neuroendocrinol | Impaired learning and memory in rats induced by a high-fat diet: Involvement with the imbalance of nesfatin-1 abundance and copine 6 expression. | 2017 | Details |
| A16751 | 28210913 | Int Urol Nephrol | Dietary and commercialized fructose: Sweet or sour? | 2017 | Details |
| A16752 | 28209760 | Diabetes | Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice. | 2017 | Details |
| A16753 | 28209193 | BMC Complement Altern Med | UP601, a standardized botanical composition composed of Morus alba, Yerba mate and Magnolia officinalis for weight loss. | 2017 | Details |
| A16754 | 28207798 | PLoS One | Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor. | 2017 | Details |
| A16755 | 28206970 | Oncotarget | Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease. | 2017 | Details |
| A16756 | 28205519 | Nat Commun | Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance. | 2017 | Details |
| A16757 | 28203453 | Iran Red Crescent Med J | Association of Osteoprotegerin with Obesity, Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Children. | 2016 | Details |
| A16758 | 28202906 | Sci Rep | BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis. | 2017 | Details |
| A16759 | 28201847 | Semin Liver Dis | The Differentiation of Intestinal-Failure-Associated Liver Disease from Nonalcoholic Fatty Liver and Nonalcoholic Steatohepatitis. | 2017 | Details |
| A16760 | 28199729 | Clin Endocrinol (Oxf) | Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort. | 2017 | Details |
| A16761 | 28195363 | Hepatology | Liver fibrosis scores predict liver disease mortality in the United States population. | 2017 | Details |
| A16762 | 28195199 | Sci Rep | Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis. | 2017 | Details |
| A16763 | 28195177 | Am J Gastroenterol | Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data. | 2017 | Details |
| A16764 | 28194671 | Dig Dis Sci | Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis. | 2017 | Details |
| A16765 | 28194666 | Dig Dis Sci | Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic. | 2017 | Details |
| A16766 | 28194019 | Cell Mol Immunol | IL-25 stimulates M2 macrophage polarization and thereby promotes mitochondrial respiratory capacity and lipolysis in adipose tissues against obesity. | 2017 | Details |
| A16767 | 28193580 | J Nutr Biochem | Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis. | 2016 | Details |
| A16768 | 28192190 | J Hepatol | β7-Integrin and MAdCAM-1 play opposing roles during the development of non-alcoholic steatohepatitis. | 2017 | Details |
| A16769 | 28192110 | Gastroenterology | Risk of Obesity-Related Cardiometabolic Complications in Special Populations: A Crisis in Asians. | 2017 | Details |
| A16770 | 28191344 | Iran Red Crescent Med J | Prediction and Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) and Identification of Its Associated Factors Using the Classification Tree Method. | 2016 | Details |
| A16771 | 28190475 | Phytomedicine | Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor. | 2016 | Details |
| A16772 | 28189916 | J Nutr Biochem | Chronic administration of saturated fats and fructose differently affect SREBP activity resulting in different modulation of Nrf2 and Nlrp3 inflammasome pathways in mice liver. | 2017 | Details |
| A16773 | 28187366 | J Nutr Biochem | A combination of dietary N-3 fatty acids and a cyclooxygenase-1 inhibitor attenuates nonalcoholic fatty liver disease in mice. | 2017 | Details |
| A16774 | 28185715 | Clin Ther | Effects of Oral Antidiabetic Drugs on Changes in the Liver-to-Spleen Ratio on Computed Tomography and Inflammatory Biomarkers in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16775 | 28185191 | Methods Mol Biol | A Coupled Approach Utilizing Immunohistochemistry and Immunocytochemistry to Visualize Cellular Lipophagy. | 2017 | Details |
| A16776 | 28184213 | Front Endocrinol (Lausanne) | Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16777 | 28183444 | Metabolism | Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis. | 2016 | Details |
| A16778 | 28183156 | J Gastroenterol Hepatol | A model to predict the onset of non-alcoholic fatty liver disease within 2 years in elderly adults. | 2017 | Details |
| A16779 | 28182612 | AIDS Rev | Non-Alcoholic Fatty Liver Disease in HIV Infection. | 2017 | Details |
| A16780 | 28181781 | Minerva Endocrinol | Thyroid dysfunction and non-alcoholic fatty liver disease. | 2017 | Details |
| A16781 | 28180059 | Mol Metab | JNK at the crossroad of obesity, insulin resistance, and cell stress response. | 2016 | Details |
| A16782 | 28179883 | Front Pharmacol | New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease. | 2017 | Details |
| A16783 | 28179090 | Dig Liver Dis | Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A16784 | 28178565 | Cell Metab | Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. | 2017 | Details |
| A16785 | 28178440 | Rambam Maimonides Med J | Comorbidities in Patients with Psoriatic Arthritis. | 2017 | Details |
| A16786 | 28177750 | Appl Physiol Nutr Metab | Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats. | 2016 | Details |
| A16787 | 28177748 | Appl Physiol Nutr Metab | Possible association between Helicobacter pylori infection and nonalcoholic fatty liver disease. | 2016 | Details |
| A16788 | 28177674 | Can J Physiol Pharmacol | Exercise restores bioavailability of hydrogen sulfide and promotes autophagy influx in livers of mice fed with high-fat diet. | 2017 | Details |
| A16789 | 28176894 | Clin Exp Gastroenterol | Autoimmune hepatitis: current challenges and future prospects. | 2017 | Details |
| A16790 | 28176415 | Pediatr Diabetes | Visceral fat is associated with the racial differences in liver fat between black and white adolescent boys with obesity. | 2017 | Details |
| A16792 | 28174796 | Rom J Morphol Embryol | Non-alcoholic fatty liver disease - clinical and histopathological aspects. | 2016 | Details |
| A16793 | 28170108 | Hepatology | Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease. | 2017 | Details |
| A16794 | 28169509 | Obesity (Silver Spring) | Nonalcoholic fatty liver disease and measures of early brain health in middle-aged adults: The CARDIA study. | 2017 | Details |
| A16795 | 28169366 | Sci Rep | Phytosterol esters attenuate hepatic steatosis in rats with non-alcoholic fatty liver disease rats fed a high-fat diet. | 2017 | Details |
| A16796 | 28167864 | J Inflamm (Lond) | Ezetimibe reduces cholesterol content and NF-kappaB activation in liver but not in intestinal tissue in guinea pigs. | 2017 | Details |
| A16797 | 28167326 | Diabetes Res Clin Pract | Association of grade of non-alcoholic fatty liver disease and glycated albumin to glycated hemoglobin ratio in patients with type 2 diabetes mellitus. | 2016 | Details |
| A16798 | 28167322 | J Hepatol | NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. | 2017 | Details |
| A16802 | 28164848 | Gastroenterol Clin North Am | Gut Microbiota and Complications of Liver Disease. | 2017 | Details |
| A16803 | 28164196 | Food Funct | Preventive effect of Silibinin in combination with Pu-erh tea extract on non-alcoholic fatty liver disease in ob/ob mice. | 2017 | Details |
| A16804 | 28163820 | Oxid Med Cell Longev | Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death. | 2017 | Details |
| A16805 | 28163011 | Obes Res Clin Pract | Aerobic endurance training improves nonalcoholic fatty liver disease (NAFLD) features via miR-33 dependent autophagy induction in high fat diet fed mice. | 2017 | Details |
| A16806 | 28162008 | Expert Rev Gastroenterol Hepatol | Clinical implications of understanding the association between oxidative stress and pediatric NAFLD. | 2017 | Details |
| A16807 | 28161992 | Am J Chin Med | Antrodia cinnamomea Prevents Obesity, Dyslipidemia, and the Derived Fatty Liver via Regulating AMPK and SREBP Signaling. | 2017 | Details |
| A16808 | 28161092 | Clin Nutr | Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials. | 2017 | Details |
| A16809 | 28160259 | J Physiol Biochem | Protein malnutrition during fetal programming induces fatty liver in adult male offspring rats. | 2017 | Details |
| A16810 | 28160250 | Curr Treat Options Gastroenterol | Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era. | 2017 | Details |
| A16811 | 28159867 | J Lipid Res | Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N-methyltransferase. | 2017 | Details |
| A16813 | 28158893 | Drug Res (Stuttg) | Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial. | 2017 | Details |
| A16815 | 28157387 | Can J Physiol Pharmacol | Trigonelline attenuates hepatic complications and molecular alterations in high-fat high-fructose diet-induced insulin resistance in rats. | 2016 | Details |
| A16816 | 28155627 | Curr Vasc Pharmacol | Surrogates of Insulin Sensitivity and Indices of Cardiometabolic Profile in Obesity. | 2017 | Details |
| A16817 | 28155087 | Curr Gastroenterol Rep | The Association Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16818 | 28154266 | Intern Med | The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma. | 2017 | Details |
| A16819 | 28153708 | Biochim Biophys Acta Mol Basis Dis | Steroidogenic acute regulatory protein (StAR) overexpression attenuates HFD-induced hepatic steatosis and insulin resistance. | 2017 | Details |